Successful alternative vaccination with BNT162b2 mRNA COVID-19 vaccine for new-onset IgA vasculitis after receiving mRNA-1273—case report

Detalles Bibliográficos
Autores principales: Morioka, Fumiyuki, Nakatani, Shinya, Tsuda, Akihiro, Mori, Katsuhito, Emoto, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483241/
https://www.ncbi.nlm.nih.gov/pubmed/36114985
http://dx.doi.org/10.1007/s13730-022-00735-w
_version_ 1784791630305296384
author Morioka, Fumiyuki
Nakatani, Shinya
Tsuda, Akihiro
Mori, Katsuhito
Emoto, Masanori
author_facet Morioka, Fumiyuki
Nakatani, Shinya
Tsuda, Akihiro
Mori, Katsuhito
Emoto, Masanori
author_sort Morioka, Fumiyuki
collection PubMed
description
format Online
Article
Text
id pubmed-9483241
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-94832412022-09-19 Successful alternative vaccination with BNT162b2 mRNA COVID-19 vaccine for new-onset IgA vasculitis after receiving mRNA-1273—case report Morioka, Fumiyuki Nakatani, Shinya Tsuda, Akihiro Mori, Katsuhito Emoto, Masanori CEN Case Rep Letter to the Editor Springer Nature Singapore 2022-09-17 /pmc/articles/PMC9483241/ /pubmed/36114985 http://dx.doi.org/10.1007/s13730-022-00735-w Text en © The Author(s) under exclusive licence to The Japan Society of Nephrology 2022
spellingShingle Letter to the Editor
Morioka, Fumiyuki
Nakatani, Shinya
Tsuda, Akihiro
Mori, Katsuhito
Emoto, Masanori
Successful alternative vaccination with BNT162b2 mRNA COVID-19 vaccine for new-onset IgA vasculitis after receiving mRNA-1273—case report
title Successful alternative vaccination with BNT162b2 mRNA COVID-19 vaccine for new-onset IgA vasculitis after receiving mRNA-1273—case report
title_full Successful alternative vaccination with BNT162b2 mRNA COVID-19 vaccine for new-onset IgA vasculitis after receiving mRNA-1273—case report
title_fullStr Successful alternative vaccination with BNT162b2 mRNA COVID-19 vaccine for new-onset IgA vasculitis after receiving mRNA-1273—case report
title_full_unstemmed Successful alternative vaccination with BNT162b2 mRNA COVID-19 vaccine for new-onset IgA vasculitis after receiving mRNA-1273—case report
title_short Successful alternative vaccination with BNT162b2 mRNA COVID-19 vaccine for new-onset IgA vasculitis after receiving mRNA-1273—case report
title_sort successful alternative vaccination with bnt162b2 mrna covid-19 vaccine for new-onset iga vasculitis after receiving mrna-1273—case report
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483241/
https://www.ncbi.nlm.nih.gov/pubmed/36114985
http://dx.doi.org/10.1007/s13730-022-00735-w
work_keys_str_mv AT moriokafumiyuki successfulalternativevaccinationwithbnt162b2mrnacovid19vaccinefornewonsetigavasculitisafterreceivingmrna1273casereport
AT nakatanishinya successfulalternativevaccinationwithbnt162b2mrnacovid19vaccinefornewonsetigavasculitisafterreceivingmrna1273casereport
AT tsudaakihiro successfulalternativevaccinationwithbnt162b2mrnacovid19vaccinefornewonsetigavasculitisafterreceivingmrna1273casereport
AT morikatsuhito successfulalternativevaccinationwithbnt162b2mrnacovid19vaccinefornewonsetigavasculitisafterreceivingmrna1273casereport
AT emotomasanori successfulalternativevaccinationwithbnt162b2mrnacovid19vaccinefornewonsetigavasculitisafterreceivingmrna1273casereport

Ejemplares similares